Ali's health is worth tens of millions of yuan to perform the good play of "borrowing the shell" to get the certificate

Source: on July 8, 2016, Alibaba health staged another "backdoor" show to get a license Ali Health recently announced that it plans to invest 16.8 million yuan to acquire all the equity of Guangzhou 5000 year pharmaceutical chain Co., Ltd (hereinafter referred to as "5000 year pharmaceutical") The latter is mainly engaged in the retail business of drugs and traditional Chinese medicine drinks, and obtained the certificate of qualification for Internet drug trading service (C certificate) in February last year, which also means that Ali health will obtain the qualification to operate its own medicine B2C business through this acquisition The head of Ali Health told the Beijing Business Daily that it will promote the image display of drug brand manufacturers online and offline through the 5000 year pharmaceutical platform, and 5000 year pharmaceutical will form cooperation and cooperation with other businesses in different categories of differentiated operation and supporting services According to Zhang Yidan, an analyst at Yiguan medical research center, getting an Internet drug license through acquisition is Alibaba health's real intention In the first half of this year, alihealth established the pharmaceutical o2o alliance, and now or will make efforts in the self-supporting B2C field In fact, this is not the first time Ali health has "borrowed the shell" to get the certificate In 2014, when Alibaba laid out tmall Pharma, it acquired certificate a of Internet drug transaction service qualification through acquisition of 95095 pharmaceutical e-commerce The policy is still wavering towards the release of online drug sales, but it does not prevent the determination of e-commerce enterprises to lay out the market in advance The cooperation between physical drugstores and Internet enterprises has become the mainstream Zhang Yidan said that o2o business cooperation between pharmaceutical e-commerce and physical drugstores is a breakthrough, and the integration of o2o and B2C, online and offline models has become a mainstream trend in the development of pharmaceutical e-commerce Pharmaceutical e-commerce B2C enterprises have complete channels for drug purchase, production and distribution, which is conducive to reducing the cost of distribution and operation However, at this stage, pharmaceutical services are still offline services With the development of vertical segmentation of internet medical services, the early mode of pure online drug sales of pharmaceutical e-commerce appears to be "light", so the combination of offline o2o and pharmaceutical e-commerce Pattern is a remedy